Genome editing platform that uses paired CRISPR/Cas guide RNAs to create targeted 2 Mbp chromosomal inversions in vegetable species, bringing commercially valuable genes into proximity for enhanced plant breeding applications.
This solution offers a genome editing approach that uses CRISPR/Cas nucleases with paired guide RNAs to create targeted chromosomal inversions of up to 2 Mbp in vegetable crops. By inducing double-strand breaks at two distant sites on the same chromosome, the platform enables the repositioning of commercially important genes into proximity, unlocking new trait combinations for plant breeding programs. The technology addresses a key limitation in conventional breeding by allowing precise structural rearrangement of the genome rather than relying on naturally occurring inversions.
The approach has been validated in model and crop species including rice, Arabidopsis, corn, and Nicotiana benthamiana, with demonstrated inversion events up to 75.4 Mbp in published studies. Prior work by the research team has confirmed that induced inversions are stably inherited across generations. The technology is positioned at TRL 4–5, having moved beyond proof-of-concept in model systems toward application in vegetable species. Future validation will involve receiving target vegetable seeds from industry partners, confirming sequence similarity at target sites, regenerating edited tissues, and conducting greenhouse-based trait evaluations to advance toward commercial readiness.
Oklahoma State University is a comprehensive public land‑grant research university with a statewide footprint anchored in Stillwater. A research and technology park connects faculty expertise with corporate partners through co‑located labs, flexible leases, and shared prototyping and pilot‑scale facilities. Integration with an academic health system in Tulsa and a veterinary teaching hospital supports clinical translation, field trials, and product evaluation. A statewide extension network and experiment stations provide industry with rapid access to real‑world testing sites and workforce pipelines. Research is supported by competitive federal funding from NSF, USDA, NIH, and DOE, alongside industry‑sponsored agreements. A dedicated technology transfer office and an affiliated incubator accelerate IP protection, licensing, and startup formation.